داروسازی ابوریحان
دابور | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 65,540 2.99
Close Price: 65,560
Balance Sheet
AGM
Interim
2026/06/29 Fiscal Year 2026/03/2012 Month | 2025/06/08 Fiscal Year 2025/03/2012 Month | 2024/05/14 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 563.502 Billion | 481.194 Billion | 393.878 Billion | |
Trade Receivables | 22.413 Trillion | 16.405 Trillion | 15.594 Trillion | |
Prepayments | 3.327 Trillion | 1.354 Trillion | 966.625 Billion | |
Raw Materials & Packaging Inventory | 3.94 Trillion | 2.865 Trillion | 2.378 Trillion | |
Work-in-Progress Inventory | 805.375 Billion | 591.383 Billion | 549.475 Billion | |
Finished Goods Inventory | 1.143 Trillion | 369.292 Billion | 185.846 Billion | |
Spare Parts Inventory | 245.394 Billion | 190.773 Billion | 152.868 Billion | |
Goods in Transit | 1.168 Trillion | 71.274 Billion | 494.669 Billion | |
Other Inventories | 10.048 Billion | -147.797 Billion | 27.715 Billion | |
Inventories | 7.215 Trillion | 3.938 Trillion | 3.762 Trillion | |
Total Current Assets | 33.519 Trillion | 22.178 Trillion | 20.717 Trillion | |
Long-Term Investments | 7.077 Billion | 59.909 Billion | 108.026 Billion | |
Long-Term Trade Receivables | - | 3.879 Billion | 7.036 Billion | |
Intangible Assets | 43.632 Billion | 50.075 Billion | 56.619 Billion | |
Property, Plant & Equipment | 429.04 Billion | 431.672 Billion | 429.457 Billion | |
Net Fixed Assets | 429.04 Billion | 431.672 Billion | 429.457 Billion | |
Total Non-Current Assets | 479.749 Billion | 545.535 Billion | 601.138 Billion | |
Total Assets | 33.999 Trillion | 22.723 Trillion | 21.318 Trillion | |
Trade Payables | 5.838 Trillion | 3.282 Trillion | 1.922 Trillion | |
Advances Received | 4.716 Billion | 151.924 Billion | 49.831 Billion | |
Income Tax Provision | 3.921 Trillion | 1.299 Trillion | 980.673 Billion | |
Proposed & Payable Dividends | 6.306 Trillion | 6.1 Trillion | 5.194 Trillion | |
Current Borrowings | 2.695 Trillion | 6.807 Trillion | 8.587 Trillion | |
Total Current Liabilities | 18.763 Trillion | 17.64 Trillion | 16.734 Trillion | |
Long-Term Borrowings | 196.845 Billion | - | - | |
Employee Termination Benefits Provision | 553.386 Billion | 414.949 Billion | 271.802 Billion | |
Total Non-Current Liabilities | 750.231 Billion | 414.949 Billion | 271.802 Billion | |
Total Liabilities | 19.514 Trillion | 18.055 Trillion | 17.006 Trillion | |
Capital | 1.8 Trillion | 1.8 Trillion | 1.8 Trillion | |
Retained Earnings | 12.63 Trillion | 2.77 Trillion | 2.364 Trillion | |
Legal Reserve | 180 Billion | 180 Billion | 180 Billion | |
Share Premium Reserve | -124.604 Billion | -81.014 Billion | -31.709 Billion | |
Total Equity | 14.485 Trillion | 4.669 Trillion | 4.312 Trillion | |
Total Liabilities & Equity | 33.999 Trillion | 22.723 Trillion | 21.318 Trillion | |
Approved Capital | 1.8 Trillion | 1.8 Trillion | 1.8 Trillion | |
Approved Retained Earnings | 6.072 Trillion | 1.619 Trillion | 563.988 Billion | |
Approved Legal Reserve | 180 Billion | 180 Billion | 180 Billion | |
Total Approved Equity (at AGM) | 8.052 Trillion | 3.599 Trillion | 2.544 Trillion | |
افزایش یا کاهش ارزش موجودیها | -79.773 Billion | - | -16.934 Billion | |
کالای امانی دیگران نزد ما | 16.972 Billion | 11.132 Billion | 9.727 Billion | |
انبار ملزومات | - | 9.701 Billion | - |
